UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 101

Sortiert nach

Bedaquiline: a review of human pharmacokinetics and drug-drug interactions

Journal of antimicrobial chemotherapy, 2014-09, Vol.69 (9), p.2310-2318

2014

Volltextzugriff (PDF)

Pharmacokinetics and Pharmacodynamics of the Non-Nucleoside Reverse-Transcriptase Inhibitor Etravirine in Treatment-Experienced HIV-1-Infected Patients

Clinical pharmacology and therapeutics, 2010-11, Vol.88 (5), p.695-703

2010

Volltextzugriff (PDF)

Ritonavir Enables Combined Therapy with Rifampin and Saquinavir

Clinical infectious diseases, 1999-12, Vol.29 (6), p.1586-1586

1999

Volltextzugriff (PDF)

Efficacy of Cerebrospinal Fluid (CSF)–Penetrating Antiretroviral Drugs against HIV in the Neurological Compartment: Different Patterns of Phenotypic Resistance in CSF and Plasma

Clinical infectious diseases, 2005-12, Vol.41 (12), p.1787-1793

2005

Volltextzugriff (PDF)

The effect of fluconazole on ritonavir and saquinavir pharmacokinetics in HIV‐1‐infected individuals

British journal of clinical pharmacology, 2001-06, Vol.51 (6), p.631-635

2001

Volltextzugriff (PDF)

Antiretroviral drugs and the central nervous system

AIDS (London), 1998-10, Vol.12 (15), p.1941-1955

1998

Volltextzugriff (PDF)

Assessment of the steady‐state pharmacokinetic interaction between etravirine administered as two different formulations and tenofovir disoproxil fumarate in healthy volunteers

HIV medicine, 2009-03, Vol.10 (3), p.173-181

2009

Volltextzugriff (PDF)

Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine

The Lancet (British edition), 1998-05, Vol.351 (9115), p.1547-1551

1998

Volltextzugriff (PDF)

Combination of protease inhibitors for the treatment of HIV-1-infected patients: a review of pharmacokinetics and clinical experience

Antiviral therapy, 2001-12, Vol.6 (4), p.201-229

2001

Volltextzugriff (PDF)

Enhanced penetration of indinavir in cerebrospinal fluid and semen after the addition of low-dose ritonavir

AIDS (London), 2000-06, Vol.14 (9), p.1187-1194

2000

Volltextzugriff (PDF)

The steady-state plasma pharmacokinetics of indinavir alone and in combination with a low dose of ritonavir in twice daily dosing regimens in HIV-1-infected individuals

AIDS (London), 1999-10, Vol.13 (14), p.F95-F99

1999

Volltextzugriff (PDF)

The effect of plasma drug concentrations on HIV-1 clearance rate during quadruple drug therapy

AIDS (London), 1998-07, Vol.12 (11), p.F111-F115

1998

Volltextzugriff (PDF)

Effect of Repeated Doses of Darunavir plus Low-Dose Ritonavir on the Pharmacokinetics of Sildenafil in Healthy Male Subjects: Phase I Randomized, Open-Label, Two-Way Crossover Study

Clinical drug investigation, 2008, Vol.28 (8), p.479-485

2008

Volltextzugriff (PDF)

Cerebrospinal fluid HIV-1 RNA during treatment with ritonavir/saquinavir or ritonavir/saquinavir/stavudine

AIDS (London), 2000-07, Vol.14 (11), p.1583-1589

2000

Volltextzugriff (PDF)

Alternative multidrug regimen provides improved suppression of HIV-1 replication over triple therapy

AIDS (London), 1998-07, Vol.12 (11), p.F117-F122

1998

Volltextzugriff (PDF)

Deep salvage with amprenavir and lopinavir/ritonavir: correlation of pharmacokinetics and drug resistance with pharmacodynamics

Journal of acquired immune deficiency syndromes (1999), 2004-04, Vol.35 (4), p.359

2004

Volltextzugriff (PDF)

Pharmacokinetic evaluation of the interaction between etravirine and rifabutin or clarithromycin in HIV-negative, healthy volunteers: results from two Phase 1 studies

Journal of antimicrobial chemotherapy, 2014-03, Vol.69 (3), p.728-734

2014

Volltextzugriff (PDF)

Once-daily dosing of saquinavir and low-dose ritonavir in HIV-1-infected individuals : a pharmacokinetic pilot study

AIDS (London), 2000-06, Vol.14 (9), p.F103-F110

2000

Volltextzugriff (PDF)

Simplifying protease inhibitor therapy with once-daily dosing of saquinavir soft-gelatin capsules/ritonavir (1600/100 mg): HIVNAT 001.3 study

Journal of acquired immune deficiency syndromes (1999), 2002-04, Vol.29 (5), p.464

2002

Volltextzugriff (PDF)

Toxicity and drug exposure in a quadruple drug regimen in HIV-1 infected patients participating in the ADAM study

AIDS (London), 2000-01, Vol.14 (1), p.59-68

2000

Volltextzugriff (PDF)

Salvage therapy with regimens containing ritonavir and saquinavir in extensively pretreated HIV-infected patients

AIDS (London), 1999-08, Vol.13 (12), p.1485-1489

1999

Volltextzugriff (PDF)

Comparison of the plasma pharmacokinetics and renal clearance of didanosine during once and twice daily dosing in HIV-1 infected individuals

AIDS (London), 1998-12, Vol.12 (17), p.F211-F216

1998

Volltextzugriff (PDF)

The role of various Bcl-2 domains in the anti-proliferative effect and modulation of cellular glutathione levels: a prominent role for the BH4 domain

Cell proliferation, 2003-02, Vol.36 (1), p.35-44

2003

Volltextzugriff (PDF)

Randomized trial comparing saquinavir soft gelatin capsules versus indinavir as part of triple therapy (CHEESE study)

AIDS (London), 1999-05, Vol.13 (7), p.F53-F58

1999

Volltextzugriff (PDF)

High exposure to nevirapine in plasma is associated with an improved virological response in HIV-1-infected individuals

AIDS (London), 2001-06, Vol.15 (9), p.1089-1095

2001

Volltextzugriff (PDF)

1 – 25 von 101

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(87)
Mit Volltextzugriff
(86)

Publikationsform

Artikel
(101)

Sprache

Englisch
(101)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Humans
(87)
Life Sciences & Biomedicine
(83)
Science & Technology
(83)
Biological And Medical Sciences
(61)
Medical Sciences
(61)
Pharmacology. Drug Treatments
(59)
Hiv Infections - Drug Therapy
(49)
Aids/hiv
(48)
Infectious Diseases
(48)
Male
(47)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(45)
Adult
(44)
Antiviral Agents
(44)
Virology
(36)
Immunology
(33)
Middle Aged
(31)
Drug Therapy, Combination
(30)
Female
(30)
Pharmacology & Pharmacy
(29)
Anti-Hiv Agents - Pharmacokinetics
(24)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Bedaquiline: a review of human pharmacokinetics and drug-drug interactions

Pharmacokinetics and Pharmacodynamics of the Non-Nucleoside Reverse-Transcriptase Inhibitor Etravirine in Treatment-Experienced HIV-1-Infected Patients

Ritonavir Enables Combined Therapy with Rifampin and Saquinavir

Efficacy of Cerebrospinal Fluid (CSF)–Penetrating Antiretroviral Drugs against HIV in the Neurological Compartment: Different Patterns of Phenotypic Resistance in CSF and Plasma

The effect of fluconazole on ritonavir and saquinavir pharmacokinetics in HIV‐1‐infected individuals

Antiretroviral drugs and the central nervous system

Assessment of the steady‐state pharmacokinetic interaction between etravirine administered as two different formulations and tenofovir disoproxil fumarate in healthy volunteers

Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine

Combination of protease inhibitors for the treatment of HIV-1-infected patients: a review of pharmacokinetics and clinical experience

Enhanced penetration of indinavir in cerebrospinal fluid and semen after the addition of low-dose ritonavir

The steady-state plasma pharmacokinetics of indinavir alone and in combination with a low dose of ritonavir in twice daily dosing regimens in HIV-1-infected individuals

The effect of plasma drug concentrations on HIV-1 clearance rate during quadruple drug therapy

Effect of Repeated Doses of Darunavir plus Low-Dose Ritonavir on the Pharmacokinetics of Sildenafil in Healthy Male Subjects: Phase I Randomized, Open-Label, Two-Way Crossover Study

Cerebrospinal fluid HIV-1 RNA during treatment with ritonavir/saquinavir or ritonavir/saquinavir/stavudine

Alternative multidrug regimen provides improved suppression of HIV-1 replication over triple therapy

Deep salvage with amprenavir and lopinavir/ritonavir: correlation of pharmacokinetics and drug resistance with pharmacodynamics

Pharmacokinetic evaluation of the interaction between etravirine and rifabutin or clarithromycin in HIV-negative, healthy volunteers: results from two Phase 1 studies

Once-daily dosing of saquinavir and low-dose ritonavir in HIV-1-infected individuals : a pharmacokinetic pilot study

Simplifying protease inhibitor therapy with once-daily dosing of saquinavir soft-gelatin capsules/ritonavir (1600/100 mg): HIVNAT 001.3 study

Toxicity and drug exposure in a quadruple drug regimen in HIV-1 infected patients participating in the ADAM study

Salvage therapy with regimens containing ritonavir and saquinavir in extensively pretreated HIV-infected patients

Comparison of the plasma pharmacokinetics and renal clearance of didanosine during once and twice daily dosing in HIV-1 infected individuals

The role of various Bcl-2 domains in the anti-proliferative effect and modulation of cellular glutathione levels: a prominent role for the BH4 domain

Randomized trial comparing saquinavir soft gelatin capsules versus indinavir as part of triple therapy (CHEESE study)

High exposure to nevirapine in plasma is associated with an improved virological response in HIV-1-infected individuals

Suchergebnisse filtern